ZyVersa Therapeutics Inc.’s Post

Attending the 2024 BIO International Convention in San Diego June 3 – June 6? To learn about ZyVersa’s differentiated Inflammasome ASC Inhibitor IC 100 and Cholesterol Efflux Mediator™ VAR 200, please schedule a one-on-one meeting with CEO, Stephen C. Glover, through the conference portal. For details: https://bit.ly/3WEqL0U

To view or add a comment, sign in

Explore topics